ADAMTS19
A disintegrin and metalloproteinase with thrombospondin motifs 19
Also known as: ATS19_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q8TE59
- Gene
- ADAMTS19
- Canonical length
- 1213 aa
- Protein class
- Predicted secreted proteins
OverviewNCBI Gene
No narrative summary is available for ADAMTS19 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
1213 residues, UniProt reviewed canonical sequence.
>Q8TE59|ADAMTS19
1 MGKNREMRLT HICCCCLLYQ LGFLSNGIVS ELQFAPDREE WEVVFPALWR REPVDPAGGS
61 GGSADPGWVR GVGGGGSARA QAAGSSREVR SVAPVPLEEP VEGRSESRLR PPPPSEGEED
121 EELESQELPR GSSGAAALSP GAPASWQPPP PPQPPPSPPP AQHAEPDGDE VLLRIPAFSR
181 DLYLLLRRDG RFLAPRFAVE QRPNPGPGPT GAASAPQPPA PPDAGCFYTG AVLRHPGSLA
241 SFSTCGGGLM GFIQLNEDFI FIEPLNDTMA ITGHPHRVYR QKRSMEEKVT EKSALHSHYC
301 GIISDKGRPR SRKIAESGRG KRYSYKLPQE YNIETVVVAD PAMVSYHGAD AARRFILTIL
361 NMVFNLFQHK SLSVQVNLRV IKLILLHETP PELYIGHHGE KMLESFCKWQ HEEFGKKNDI
421 HLEMSTNWGE DMTSVDAAIL ITRKDFCVHK DEPCDTVGIA YLSGMCSEKR KCIIAEDNGL
481 NLAFTIAHEM GHNMGINHDN DHPSCADGLH IMSGEWIKGQ NLGDVSWSRC SKEDLERFLR
541 SKASNCLLQT NPQSVNSVMV PSKLPGMTYT ADEQCQILFG PLASFCQEMQ HVICTGLWCK
601 VEGEKECRTK LDPPMDGTDC DLGKWCKAGE CTSRTSAPEH LAGEWSLWSP CSRTCSAGIS
661 SRERKCPGLD SEARDCNGPR KQYRICENPP CPAGLPGFRD WQCQAYSVRT SSPKHILQWQ
721 AVLDEEKPCA LFCSPVGKEQ PILLSEKVMD GTSCGYQGLD ICANGRCQKV GCDGLLGSLA
781 REDHCGVCNG NGKSCKIIKG DFNHTRGAGY VEVLVIPAGA RRIKVVEEKP AHSYLALRDA
841 GKQSINSDWK IEHSGAFNLA GTTVHYVRRG LWEKISAKGP TTAPLHLLVL LFQDQNYGLH
901 YEYTIPSDPL PENQSSKAPE PLFMWTHTSW EDCDATCGGG ERKTTVSCTK IMSKNISIVD
961 NEKCKYLTKP EPQIRKCNEQ PCQTRWMMTE WTPCSRTCGK GMQSRQVACT QQLSNGTLIR
1021 ARERDCIGPK PASAQRCEGQ DCMTVWEAGV WSECSVKCGK GIRHRTVRCT NPRKKCVLST
1081 RPREAEDCED YSKCYVWRMG DWSKCSITCG KGMQSRVIQC MHKITGRHGN ECFSSEKPAA
1141 YRPCHLQPCN EKINVNTITS PRLAALTFKC LGDQWPVYCR VIREKNLCQD MRWYQRCCET
1201 CRDFYAQKLQ QKSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADAMTS19 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 9.5 nTPM
Expression across tissuesHPA
Tissue
- cervix: 9.5 nTPM
- endometrium: 9.2 nTPM
- smooth muscle: 5.5 nTPM
- placenta: 3.5 nTPM
- fallopian tube: 2.1 nTPM
- basal ganglia: 1.4 nTPM
Single-cell type
- podocytes: 1,207 nCPM
- adrenal medulla cells: 394 nCPM
- cytotrophoblasts: 256 nCPM
- brain inhibitory neurons: 222 nCPM
- myonuclei: 171 nCPM
- endometrial stromal cells: 139 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 9.4 nTPM
- cerebral cortex: 7.3 nTPM
- hippocampal formation: 3.8 nTPM
- white matter: 3.6 nTPM
- midbrain: 3.5 nTPM
- thalamus: 2.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADAMTS19.
Disease | AllUniProt
Conditions ADAMTS19 is implicated in, by any mechanism.
- Cardiac valvular dysplasia 2 (CVDP2) MIM:620067
Disease | GeneticClinVar
11 pathogenic / likely-pathogenic of 217 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cardiac valvular dysplasia 2
- ADAMTS19-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.1
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aortic valve morphogenesis
- collagen fibril organization
- extracellular matrix organization
- mitral valve morphogenesis
- proteolysis
- pulmonary valve morphogenesis
- tricuspid valve morphogenesis
- ventricular septum morphogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thrombospondin type-1 (TSP1) repeat
- Peptidase M12B, ADAM/reprolysin
- ADAM, cysteine-rich domain
- ADAMTS/ADAMTS-like, Spacer 1
- PLAC
- ADAMTS/ADAMTS-like
- Metallopeptidase, catalytic domain superfamily
- Thrombospondin type-1 repeat superfamily
- ADAMTS, cysteine-rich domain 2
- ADAMTS and ADAMTS-like
- A disintegrin and metalloproteinase with thrombospondin motifs 17/19, C-terminal helical domain
- Thrombospondin type 1 domain
- Reprolysin (M12B) family zinc metalloprotease
- ADAM-TS Spacer 1
- ADAMTS cysteine-rich domain 2
- Thrombospondin type 1 domain
- ADAMTS C-terminal helical domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADAMTS19 as an antibody target. Whether an autoantibody or antibody against ADAMTS19 could matter depends on whether native ADAMTS19 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADAMTS19 is annotated as secreted, so native ADAMTS19 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ADAMTS19 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...